Controversies in ICD/CRT implantation in non-ischemic cardiomyopathy for primary prevention
Description
With Nicolas Verheyen, Medical University of Graz, Graz - Austria, and Lars Kober, Rigshospitalet, Copenhagen University Hospital, Copenhagen - Denmark.
In this episode of HFA CardioTalk, Nicolas Verheyen interviews Lars Kober on controversies in ICD/CRT implantation in non-ischemic cardiomyopathy for primary prevention. They focus in particular on the importance of selecting the right patients, and discuss biomarkers beyond left ventricular ejection fraction that may add value in predicting sudden death risk, and the need of randomized controlled trials with adequate endpoint selection to guide prophylactic ICD implantation.
Related scientific paper:
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- 2023 ESC Guidelines for the management of cardiomyopathies
- Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
- 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)
This 2024 HFA CardioTalk podcast serie is supported by Novartis in the form of an educational grant. The discussion has not been influenced in any way by its sponsor.
United States
